Posts by Muana Minkoué
Oculis just announced positive topline results of phase 2b RELIEF Trial
Oculis, announced positive topline results from its Phase 2b RELIEF trial with licaminlimab, a novel anti-TNFα biologic eye drop with an established dual anti-inflammatory and anti-apoptotic mechanism of action in patients with dry eye disease (DED). The Phase 2b RELIEF trial is a multi-centre, randomised, double-masked, vehicle-controlled trial evaluating the efficacy and safety…
Read MoreLimula raises CHF 6.2 Million
Limula raises CHF 6.2 Million in oversubscribed Seed round to develop automated Cell and Gene Therapy manufacturing platform. The oversubscribed seed round was led by LifeX Ventures, with participation from the founders, Verve Ventures, Zühlke Ventures, Oxford Seed Fund, Lichtsteiner Foundation, W.A. de Vigier Foundation, and a line-up of private individuals who have…
Read MoreMyota publishes new clinical trial results in pre-diabetes
Myota is thrilled to announce that their results have been published in the prestigious British Journal of Nutrition, and the results are nothing short of groundbreaking. In this study, Myota showed that pre-diabetic patients given Myota fibres showed significant improvements in insulin sensitivity, systemic inflammation, and HbA1c in individuals earlier on in the…
Read MoreOrio Therapeutics receives CHF 150’000 from Venture Kick
Orio Therapeutics obtains the CHF 150,000 Kick to redefine regenerative medicine through protein engineering. Orio Therapeutics modifies therapeutic proteins using a patented technology. This modification improves drug delivery by controlling the localisation of the protein after injection. Its approach ensures enhanced efficacy and reduced dosage, addressing the limitations of uncontrolled drug delivery in…
Read MoreBilan’s 2024 Top 40 entrepreneurs below 40 in Western Switzerland
Bilan Magazine identifies the founders of companies under 40, with sales of CHF 1 million or more. This annual operation highlights the achievements and projects of the new generation at the helm of fast-growing companies. Check out the Swiss Health Valley entrepreneurs listed in the third edition of the Top 40 Entrepreneurs Under…
Read MoreSIB Profile 2024 – Data scientists for life
The Swiss Institute of Bioinformatics (SIB) latest activity report sets out how SIB contributes to Switzerland’s influence in the life sciences, from fighting diseases or supporting innovation to promoting scientific excellence and open science. This year’s report focuses on two themes: the revolution that generative artificial intelligence is bringing to life science research, and…
Read MoreDamian Müller elected Swiss Medtech President
Damian Müller was elected President of Swiss Medtech at its last General Meeting. The 39-year-old Council of States member from Lucerne succeeds Beat Vonlanthen, who is handing over leadership of the Swiss medical technology association after six years. The Assembly also elected two female entrepreneurs, Juliette von Arx, CEO of Lifestage Solutions AG,…
Read MoreHeroSupport wins Prix Strategis
The 31st Prix Strategis closing ceremony crowned start-up Herosupport. Last night, HeroSupport SA distinguished themselves among 90 innovative competitors to win this year’s Prix Strategis , along with CHF 50,000. Their groundbreaking product, VENUS SHELL™, a personalized 3D-printed solution, is transforming radiation treatment by enhancing MRI accuracy and improving patient comfort. Every year…
Read MoreDiabète, Même Pas Peur ! wins the FIT Impact grand prize
The Foundation for Technological Innovation (FIT) has awarded its very first FIT Impact award. The Foundation has launched the FIT Impact programme to supports projects that do not require a technological or digital dimension. Diabète, Même Pas Peur ! wins CHF 20’000. Diabète, Même Pas Peur ! aims to to turn the challenges…
Read MoreDAAV secures CHF 1 Million
DAAV, a pioneering startup revolutionising mobility services for people with reduced mobility, announced the successful closure of its first funding round. The investment was led by Spicehaus Partners. DAAV is dedicated to providing an inclusive travel experience for individuals with reduced mobility, particularly in airport settings. With its AI-enabled mobility device, DAAV-air, the…
Read More